Electroporation was applied to enhance gene transfer into subcutaneous MC2 murine breast tumors. Cultured MC2 cells were also transfected by electroporation or by cationic liposomes in the presence of serum using pSV-luc plasmids. Electroporation parameters and liposome formulation were optimized to achieve the highest relative levels of transfection. An electric field threshold for successful electrotransfection in cultured cells appeared around 800-900 V/cm. The liposomes used contained the cationic lipid dioleoyl-3-trimethylammonium propane (DOTAP). Multilamellar vesicles (MLV) had a 10-fold advantage over small unilamellar vesicles (SUV) in cell culture transfection. For in vivo gene delivery, the plasmids were injected either alone, or in complex with MLV or SUV DOTAP liposomes. A series of six electric
Introduction
Gene therapy is fast becoming a therapeutic mode for cancer therapy. Many new vectors have been designed for effective gene transfer. Among these newly developed vectors, nonviral vectors have several advantages over retroviral and adenoviral vectors in gene delivery for cancer therapy. For instance, some retroviruses are capable of activating oncogenes or deactivating tumor suppressor genes. In addition, nonviral methods such as cationic liposomes, cationic polymers and electroporation do not usually elicit immune responses. Therefore, they can be repeatedly administered. However, the gene transfer efficiency of nonviral vectors is still below that of viral vectors. Long-term expression is still a challenge for nonviral methods. With advanced liposome designs and improved electroporation technology, the combination of cationic liposomes and electroporation holds promise for enhanced local gene delivery.
Electroporation is a highly efficient method for delivering exogenous molecules, including DNA, into cells. This method has been used widely as means to deliver molecules into cells in vitro. 1 Recently, this method has been applied to permeate the upper layer (stratum corneum) of the skin for the purpose of drug and gene delivery. 2, 3 The possibility of applying surface
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electrodes and create electric field gradients through soft tissues makes electroporation an attractive method for gene delivery to tumors of the head, neck, breasts and skin. In vivo electroporation has been applied to introduce bleomycin to solid tumor cells with significant tumor suppressing effects. 4, 5 This therapeutic mode is at phase I/II clinical trial. 6 However, the application so far is restricted to membrane transport-limited drugs, (ie bleomycin). For cancer gene therapy, a promising approach is the partial transfection of tumors and surrounding cells with genes coding for biological modulators (eg cytokines), or the limited transfection of antigen-presenting cells for enhancing immunotherapy. Current attempts to inject cytokines have limited success, because these agents produce strong inflammatory responses and edema. Localized gene therapy allows for long-term production of these agents in the immediate vicinity of tumors. Transfecting a fraction of tumor cells with apoptotic (eg Tk), tumor necrosis factor, or tumor suppressor genes may also be beneficial, taking advantage of bystander effects upon neighboring cells.
An earlier electrotransfection experiment, using surface electrodes on skin, was reported by Titomirov et al, 7 delivering plasmids coding for a reporter gene into newborn mouse skin. They reported transient and long-term transfection of cells isolated and cultured from electroporated skin. Zhang et al 8 also reported transfection of skin cells with the LacZ reporter gene, using a combination of electric pulse and pressure. Recent studies have shown that electroporation applied in vivo can introduce reporter genes to murine liver, and indirectly to rat brain tumor. 9, 10 Rols et al 11 have demonstrated the possibility of electrotransfection of melanoma in vivo.
To show that electroporation can significantly enhance gene delivery to tumors, we applied electroporation to a large number of implanted murine breast tumors. Because of tumor heterogeneity, studies involving many tumor samples are needed to establish a statistical basis for the usefulness of electroporation in gene delivery to tumors. Altogether, 105 tumors were used in this experiment. Variability in tumor size and appearance was examined both visually and by palpation for its effect on transfection rates. Furthermore, the effects of different types of liposomes as adjuvant vectors were examined. The purpose is to establish the usefulness of electroporation with or without liposomes for gene delivery to solid tumors. The efficiencies and conditions for in vitro and in vivo transfections, using the same tumor cells and plasmids, are compared. This study illustrates the potential of local gene delivery to solid tumors by applying electric pulses with surface electrodes in a way comparable to a clinical setting.
Results

Tumor classification
In order to improve the reproducibility of gene expression in a heterogeneous population of tumors, we classified tumors into medium-large (8-15 mm wide) and small (Ͻ8 mm) groupings. Smaller tumors tended to be firm, well vascularized, and fast growing, without areas of apparent necrosis. Medium-sized tumors were almost as firm, with slightly uneven regions of growth and little or no apparent necrosis. Large tumors (Ͼ11 mm) tend to be the least firm with variable regions of growth and may contain non-growing regions. Most data presented in our studies of electroporation are from the medium-large group. Differences in luciferase expression between medium and large tumors were minor. Data from the small tumor group are presented separately.
Gross anatomical features of the tumors were recorded at the time of injection. The apparent viability of several tumors changed during the period between injection/electroporation and time of death. In few cases, we noted the unambiguous appearance of scabs, or eschar-like lesions, and large areas of non-cellular fluid in the tumors 2 days after electroporation. This was not observable in most cases, though. Any apparent necrosis was noted at time of death. Tumors with apparent necrotic centers were excluded from the analysis. Sample tumors were cryosectioned for microscopic observation. When escharosis did appear, it was noted mostly on surfaces contacting the electrodes.
In situ PCR Figure 1 shows in situ PCR results from tumors that were injected with no DNA, injected with DNA, but unpulsed, and tumors injected with DNA and pulsed at 1.2 kV/cm. Sections from control tumors showed very little fluorescence. The tumor with injected plasmids had considerably more fluorescent cells than the control. The highest numbers of fluorescent cells were found in sections from tumors which had been electroporated following injection of the plasmid.
Transfection of cultured MC2 tumor cells
In order to establish the transfectability of MC2 cells by liposome and electroporation methods, using the same plasmid that would be used in in vivo experiments, we first tested the cells and methods in vitro. The in vitro experiments, using cultured MC2 cells, provided us with a starting point in terms of lipoplex types and concentrations, as well as electrical parameters for subsequent in vivo experiments. Table 1 shows the transfection efficiency using lipoplexes made from DOTAP MLV or SUV, as well as MLV or SUV with DOTAP/DOPE at a 1:1 molar ratio. The charge ratio for lipid:DNA was 1:2, giving the complex a net negative charge. As with most other cells we tested, lipoplexes made of MLV were more efficient than those made of SUV. 12 With this particular cell line, DOTAP alone was as effective as DOTAP/DOPE mixture. Therefore, lipoplex of DOTAP alone was used in subsequent experiments.
Electrotransfection results are shown in Figure 2 . A pulse field strength threshold is found at 800-900 V/cm, for both plasmid concentrations (162.5 and 650 g/ml) we used. At high pulse field strength of 1600 V/cm, the transfection efficiency drops due to increased cell death. Lower transfection efficiency for samples with higher plasmid concentration at the optimal field strength may indicate membrane damage by DNA transport during electroporation. 13 
Transfection of tumors without electroporation
The relative levels of transfection by injecting naked DNA or lipoplexes made from SUV or MLV are shown in Figure 3 . All tumors were injected in the same day, without electroporation, then analyzed 2 days later. A P value Ͻ0.05 is considered to be significantly independent of chance for two results to be distinct. The differences between SUV and naked DNA and between SUV and MLV are significant. SUV lipoplexes transfected more than twice as well as naked DNA or MLV lipoplexes on average. (Note that the Y-axis of Figure 3 is in log 10 scale.) The consistency of the results gave a small standard error for each. The background level of relative light units (RLU) was subtracted from all data values for this and all other experiments.
Improving tumor transfection by electroporation
Relative levels of transfection of medium-large tumors with SUV lipoplexes are enhanced by electroporation, as shown in Figure 4 . Bars in the middle of each cluster represent average values of transfection for each applied pulse field strength category. The average values were calculated from the logarithmic values, then converted to the antilog value for plotting. From the scatter plot of data points in each pulse field category, it is apparent that there is a threshold electric field strength value for successful electroporation enhancement. This threshold occurs at field strengths between 400 and 800 V/cm. Above the threshold, the levels of transfection do not differ significantly from field value to field value, allowing for the variability within each category. Their average values are greater than those below the threshold by one to two orders of magnitude. The differences are significant, apart from one test pair (400 V/cm against 1600 V/cm). At this high end of applied field strength (1600 V/cm), there appears to be a slight decline of transfection enhancement. Transfection was much poorer at pulse fields as high as 4000 V/cm (data not shown). Transfection results from injected but unpulsed samples are again significantly higher than those from uninjected (control) samples. Statistical analysis of SUV lipoplex data is given in Table 2 . Since there was no indication that electroporation with an electric field above 1100 V/cm produced any advantage, further pulsing at high field strengths was discontinued. Because of the spread in data, there are no statistically significant differences in transfection results between any of the pulse field strengths at 800-1600 V/cm range. Levels of transfection in medium-large tumors injected with naked DNA are also enhanced by electroporation, as shown in Figure 5 . The data show similar trends to SUV lipoplex injected tumors. Naked DNA and MLV Gene Therapy lipoplexes, which likewise transfected well at 800 V/cm, were not tested with electroporation below that field strength. There are no data for the 1600 V/cm field strength due to loss of mice and tumor necrosis. Transfection with electroporation at 2300 V/cm had the highest value for any naked DNA injected tumor. The range of transfection values was also the greatest at this field strength. Consequently, the t test of the pair (0 V/cm against 2300 V/cm) is not significant. This is similar to the comparisons involving 1600 V/cm category in SUV lipoplex results. On an average, those transfections at the 800-1100 V/cm range are again one to two orders of magnitude greater than that of unpulsed control. Statistical analysis of naked DNA data is given in Table 3 .
Transfection of small tumors with naked DNA is shown in Table 4 . Data from smaller tumors showed a trend towards higher relative transfection levels at higher electric fields. Transfection with SUV lipoplexes showed the same trend (data not shown). The P values for 0 versus 1600 V/cm and 0 versus 2300 V/cm were statistically significant, 0.012 and 0.0007, respectively. The values for 0 versus 1100 V/cm and 1100 versus 2300 V/cm were 0.096 and 0.056, respectively.
Because of the similarity in transfection levels and pulse field thresholds in naked DNA and SUV lipoplex data sets, data on MLV lipoplex transfection were collected only at the three most successful field strengths for the naked DNA and SUV experiments: 800, 1100 and 1600 V/cm. Again, no significant difference was found between transfection levels of these three field strength settings. It is, therefore, reasonable to pool the transfection data in the 800-1600 V/cm range for each of the naked DNA, SUV, and MLV lipoplexes treatment groups measured at different days. The transfection levels of these three treatment groups are compared in Figure 6 . The difference between MLV and naked DNA was insignificant. The two-fold difference in average transfection levels between SUV complexes and DNA and MLVs was not statistically significant, under their most successful electrotransfection conditions. P values for SUV versus DNA and SUV versus MLV were 0.39 and 0.42, respectively. 
Discussion
Although electroporation has been applied successfully in gene delivery to cells in vitro in many cases, reports on gene delivery in vivo, especially to tumor tissues, has been scanty. A major difficulty of in vivo gene delivery to tumors is the tissue heterogeneity. Reliable, quantitative conclusion can be derived only if a large number of tumors is used. We have not known of any study at this scale.
As indicated by the results, the optimal conditions for in vivo and in vitro experiments are significantly different. For instance, lipoplexes made of cationic MLV are much more effective than SUV in transfecting cultured MC2 cells (Table 1) , while naked DNA (without electroporation) is rarely effective. However, the differences in relative transfection levels among these preparations are not very pronounced in vivo, with (Figure 6 ), or without electroporation (Figure 3 ). This is supported by subsequent control experiments in electroporation studies. Injection of naked DNA or SUV lipoplexes without electroporation resulted in higher RLU than uninjected tissues (P = 0.0026 and 0.034, respectively in Tables  2 and 3 ).
The amount of DNA injected was chosen to be below the quantity which would cause high levels of toxicity to the tumor cells. The 40 l volume injected caused limited tumor swelling at the time of injection without significant leakage of injected DNA from the tumor. This amount is consistent with quantities used by other researchers. 5, 9 The in situ PCR data in Figure 1 shows that in vivo electroporation considerably increases DNA uptake in tumors cells over nonelectroporated tumors. Fluorescence microscopy showed a majority of the tumor cells were transfected in the vicinity of the needle injection site in the pulsed tumors, but not in the unpulsed, injected tumors. The background fluorescence in the control tumor was due to endogenous tumor autofluorescence. Comparison with pulsed tumors not injected with plasmid DNA showed comparable minor background fluorescence to unpulsed controls. In situ fluorescence was therefore not due to an artifact of the electroporation itself. The in situ PCR results agree well with the trend detected by transfection with plasmids containing the luc gene.
For transfecting cultured cells in vitro, because plasmid DNA is accessible to all cells, the determining factor is the transport of plasmid DNA into cells. Endocytosis is believed to be the major route of cellular uptake of plasmid DNA in the case when lipoplexes are used as vehicles. 14 The physical state of the lipoplexes is an important factor in the uptake process. Because of their size, lipoplexes made from MLV have an advantage over those from SUV for uptake by endocytosis, and naked DNA is ineffective because it is not present on the cell surface to a significant extent. 12 On the other hand, in vivo injected plasmid DNA is accessible only to a portion of tissue cells. The determining factors could be the readiness of naked DNA or lipoplexes to extravasate, penetrate, electrophorese and diffuse through tumor tissues. The integrity of the tumor vasculature plays an important role here. In this case, naked DNA and SUV lipoplexes may have an advantage over MLV because of their smaller sizes. The difference, however, is not always significant (P = 0.014 and 0.17 for SUV/MLV and Gene Therapy MLV/naked DNA, respectively). Naked DNA is known to be effective in gene delivery to muscles 15 and other tissues, and may contribute to the higher than control transfection level in vivo (Figure 3) .
The comparison between in vivo and in vitro electrotransfection experiments is more favorable. The pulse field thresholds for electroporation in vivo and in vitro are similar, although the threshold for in vivo electrotransfection is more difficult to define. The pulse field distribution through cells in an electroporation chamber in vitro is well controlled, while the field distribution in tumors is subjected to heterogeneous tissue conductivity, not to mention the abrupt drop of the electric field gradient across the stratum corneum of the skin surrounding the tumor. It is not surprising that in vivo results are more scattered.
For both electroporation and injection alone data, there is considerable scattering of more than an order of magnitude. The large scattering can be attributed to the biological variations among tumor tissues and from tumor to tumor. Retention of the injected DNA by the tumors adds to the variability. For electroporation data, additional variables such as the effective electrical resistance of tumors, contact between electrodes and skin surface, site of DNA injection with respect to the orientation of electrodes, and extravasation of DNA into surrounding tumor tissue differ from case to case, certainly contributing to the data scattering. In general, tumors that appeared less firm and more scarred usually had low levels of relative luciferase expression. SUV lipoplex data points tend to scatter more than naked DNA data ( Figures 4, 5 and 6 ), indicating that entrance of larger lipoplexes into cells demands more critical membrane disruption. The condition to create large membrane disruption, as opposed to small pores for DNA molecule transport, is more affected by tumor structure.
The skin contributes a significant proportion of the electrical resistance during electroporation. In almost all cases, especially in larger tumors, the electric resistance of tumors dropped appreciably after the first few pulses. The resistance drop is indicative of the breakdown of the skin barrier and/or tissue cell membranes. The decrease of resistance leads to increase in current by subsequent pulses. Increases in current within a tumor lead to cell death. Although cell death within the tumor is beneficial in cancer treatment, it defeats the purpose of transfection, and adds to the uncontrolled variability of results. By microscopy in vitro, we found cell mortality to be low at electric field strengths at or below 900 V/cm. In vivo the applied electric field threshold which produced a similar low level of cell mortality was higher than 900 V/cm. Because of pulse-induced cell death in the tumors, fewer electric pulses might have given more consistent results.
The enhancement of transfection by electroporation is significant, given the scattering of data points. For both SUV lipoplexes and naked DNA injections, tumors subjected to electroporation of 800-1100 V/cm resulted in significant improvement of transfection over unpulsed controls (P Ͻ 0.01 and ෂ0.02, respectively). No significant difference is found among results derived from tumors pulsed at field strengths greater than 800 kV/cm. Higher field pulses (Ͼ1600 V/cm) tend to induce more data scattering, especially toward a low transfection range, perhaps due to increased mortality caused by the electric field. In the case of SUV lipoplexes, samples pulsed at lower fields (400 V/cm) are no different from unpulsed samples (P = 0.24), indicating a threshold pulse field strength between 400 and 800 V/cm. The exact electric field threshold probably varies somewhat from tumor to tumor. The variable electrophoretic movement of DNA during the pulse time may also account for the uncertainty of the exact threshold value. This threshold value is comparable to that given by Heller et al 9 for the electrotransfection of rat liver, and higher than that reported by Rols et al 11 for electrotransfection of melanomas. It appeared from the data ( Table 4 ) that the transfection of smaller tumors increases with stronger electric fields within the experimental range above the electric field threshold of 800 V/cm. Medium-large tumors showed less voltage dependence above the 800 V/cm threshold. Small tumors were more consistently firm and well vascularized. Their earlier stage of development may render them less susceptible than medium or large tumors to pulse-induced mortality over the 2-day period between electroporation and death of the animal. This may result in higher viability and hence transfection levels at higher pulse fields.
Our results show that electroporation enhances local gene delivery by about two orders of magnitude ( Figures  4 and 5) . The effectiveness is proven through experiments on a large number of tumor samples. As seen from Figure  6 , the choice of whether to use liposomes or naked DNA with a local injection does not make a statistically significant difference. This is our most important finding. The condition for enhancement of gene delivery is not yet optimized. Further experiments on reducing the number of pulses and using a series of pulses of decreasing field strength may further improve the enhancement ratio. Selection of smaller tumors alone could improve the data scattering. We believe that, as accuracy and efficiency improve, in vivo electroporation will become an important adjuvant therapeutic mode in the future.
Materials and methods
Growth of MC2 mammary tumors MC2 murine mammary tumors, which were derived from inbred C3H/He mice, were propagated in a consanguineous colony. MC2 cells and the initial inbred C3H mice were a gift from Dr Jan Vaage of this institute. 10 6 cultured MC2 cells were injected subcutaneously into the lateral regions of inbred C3H mice, 4-7 weeks before transfection experiments. By then tumors grew to diameters ranging from small (0.4-7 mm) to large (8-15 mm) . Tumor growth between the time of transfection and the time of death was generally minor.
Preparation of plasmid DNA and lipoplexes pSV-␤-galactosidase and pGL3 luciferase plasmids were purchased from Promega (Madison, WI, USA). Originally the ␤-galactosidase plasmids were used instead of luciferase plasmids, until it was discovered that the endogenous ␤-galactosidase levels of the tumors were too high to be used in vivo. Mammalian ␤-galactosidase genes are not homologous to the bacterial ␤-galactosidase sequences of the pSV plasmids used, therefore the in situ PCR results were unaffected by mouse ␤-galactosidase genes. The plasmid DNA were injected intratumorally, either alone ('naked DNA') or in a complex form with the cationic lipid DOTAP. The amount of DNA injected was always 25 g, in a total volume of 40 l. For naked DNA injection, the plasmid was dissolved in TE buffer. For liposome complex (lipoplex) injection, lipoplexes were made either with MLVs or with SUVs of DOTAP, with or without the addition of a helper lipid, DOPE. All lipids were purchased from Avanti Polar Lipids (Alabaster, AL, USA). The lipids in chloroform solution were dried in vacuo for 4 h, then resuspended as MLVs by vortexing for 20 s in PBS. SUVs were made by sonicating MLVs for 10 min in a bath-type sonicator. The initial size range of SUV was typically 3 nm in diameter, as measured by quasi-elastic light scattering (Nicomp 300 Particle Sizer, Santa Barbara, CA, USA). Both lipoplexes of SUV/DNA and MLV/DNA were formed by mixing DNA and lipid at a 1:2 (lipid:DNA) charge ratio.
Transfection of MC2 cells in vitro
For transfection by lipoplex, 3 × 10 6 cells in suspension were cultured in 5 ml RPMI 1640 medium with 7% fetal bovine serum, in each well of six-well plates. Transfection with lipoplexes containing 0.1 mol plasmid DNA and 0.05 mol cationic lipid per well was carried out in the presence of 7% serum for 4 h, after which the cell suspension was centrifuged and resuspended in fresh medium. For electrotransfection, 15 l of cells at a concentration of 5 × 10 7 cells/ml in B+K buffer were mixed with uncomplexed plasmids in a custom made electrode chamber. 13 Cells were pulsed six times with 1 ms pulses at specified field strengths. Immediately after pulsing, cells were resuspended in 100 l of medium and incubated for 20 min at 37°C. Then cells were transferred into 1 ml of fresh medium.
After 24 h, cells in suspension were centrifuged, supernatant removed and 250 l of cell lysis buffer (Promega) was added. Lysed cells + lysis buffer were centrifuged at 11 000 g for 10 s to remove cell debris. Extracts were assayed by adding 100 l of luciferin reagent to 10 l of the lysed cell solution. Luciferase activity of the supernatant was measured for 10 s with a Lumat LB 9501 luminometer (Berthold, Dallas, TX, USA).
In vivo electroporation
Electric pulses were delivered to tumors via a custombuilt electrode pair. This parallel pair of stainless steel electrode plates was constructed on calipers to deliver a uniform pulse across a measured distance (0.3-1.0 cm). The design of the calipers permitted direct measurement of the width between the electrodes. The area of the electrodes actually in contact with the skin was around 0.5 cm 2 . Signa electrode gel (Parker Laboratories, Fairfield, NJ, USA) was smeared lightly on the surface of the electrodes. The use of electrode gel was necessary to improve consistency of the pulses and to overcome irregularly shaped surface features and the resistance barrier of mouse hair. The gel greatly increased the reproducibility of the pulse parameters (voltage and current) across tumor tissues. A Velonex (Venus, CA, USA) model 345 pulse generator was used to deliver 1 ms square wave pulses. Six consecutive pulses, 2 s apart, were delivered to each tumor in two different directions normal to the axis of the injection needle path.
In situ PCR
We developed an in situ PCR protocol for the detection of plasmid ␤-galactosidase DNA uptake into tumor cells transfected in vivo. Control tumors received no injection of plasmid DNA. Unpulsed tumors were injected with 25 g pSV ␤-gal plasmids, but were not electroporated. Pulsed samples were injected with 25 g ␤-gal plasmids and pulsed six times at an electric field strength of 1.2 kV/cm. Mice were killed 6 h after injection/ electroporation. Tumors were removed and immediately frozen in liquid nitrogen. The frozen tumors were embedded and mounted in Cryo-gel embedding medium (Instrumedics, Hackensack, NJ, USA). Several 4-6-m thick sections were cut from the frozen tumors and placed on microscope slides, fixed overnight in a 4% formalin, 0.25 m PBS solution and subjected to in situ PCR the next morning. The sections were washed three times with PBS and treated with Proteinase K (0.01 mg/ml) at 37°C for 16 min and rinsed with distilled water. The sections were then dehydrated through a series of ethanol washes (10, 30, 60 and 100% ethanol in PBS) and airdried. A gasket was placed around each section to form a chamber and 80 l of a PCR reaction mix added to the sections and covered using a glass cover slip. The PCR reaction mix contained 10 mm Tris, 50 mm KCl, 1.5 mm MgCl 2 , 200 m each of dATP, dCTP, dGTP and dTTP, 10 units TAQ polymerase. 200 pmol of each of the two each primers were added to the PCR mix. Fluorescein-12-dUTP, 22 pmol (Boehringer Mannheim, Indianapolis, IN, USA) was added to the PCR mix to enable fluorescence detection of the PCR product. The primer sequences were obtained using the GCG program and the two 18-mer primers were synthesized at the Biopolymer Facility of the institute. The slides with the sections were placed on a custom designed copper plate and placed on the heating plate of the thermal cycler (Perkin Elmer GeneAmp PCR 9600). PCR was run for 30 cycles using standard protocol. The sections were then first washed with SSC (300 mm NaCl, 30 mm Na Citrate, pH 7.0) followed by a final wash with distilled water and air-dried. The labeled sections were examined and photographed using an Olympus IMT-2 fluorescence microscope.
Transfection assay
Forty-eight hours after the injection of DNA or lipoplex, with or without electroporation, mice were killed and tumors removed. Tumors were frozen in liquid nitrogen until ready for homogenization. PBS without Mg 2+ was added to tumor extracts at a 9:1 volume ratio. Tumor tissues were thawed, then homogenized on ice for 20 s at a medium high setting in a Polytron tissue homogenizer (Brinkmann Instruments, Mississauga, ON). Extracts were twice centrifuged for 10 min in a microcentrifuge at 11 000 g. The supernatant transferred into new tubes each time. 100 l of extract was mixed with 300 l luciferin assay reagent (Promega). Luciferase activity of the supernatant was measured for 30 s by luminometer. Relative light units (RLU) were normalized to miligrams of sample proteins, as determined by a BCA protein assay (Pierce Chemicals, Rockford, IL, USA). Optical density values for the protein assay were measured in a Beckman DU-40 spectrophotometer (Fullerton, CA, USA).
Results from all tumors treated with the same proto- 
